Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Kyowa Hakko antiparkinsonian enters phase II trials

Sep. 15, 1997

Preclinical studies show broad antiseizure properties of ganaxolone

Sep. 15, 1997

Capases: a new target for neurodegenerative disease therapy

Sep. 12, 1997

Essential tremor gene located by Icelandic genomics company

Sep. 12, 1997

Focus on Alzheimer's disease research in the U.S.

Sep. 12, 1997

Novartis launches Exelon

Sep. 11, 1997

New atypical antipsychotic agent from HMR

Sep. 11, 1997

New opioid analgesics from Astra

Sep. 11, 1997

SAR reported by Parke-Davis for series of N-type Ca2+ antagonists

Sep. 10, 1997

Tachykinin receptor antagonists developed at Janssen

Sep. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...